The increasing surgical procedures and technological advancements in tissue adhesive products and aging population across the globe are driving the growth of the Tissue Adhesives Market at a CAGR of 9.06% during the forecast period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Tissue Adhesives Market” that contains the information from 2019 to 2035.

The Global Tissue Adhesives Market is estimated to register a CAGR of 9.06 % during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Tissue Adhesives Market — Meyer-Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC, Becton, Dickinson and Company, B. Braun SE, Artivion, GEM SRL, Advanced Medical Solutions, Cohera Medical, Inc. and others.

The Global Tissue Adhesives Market accounted for registering a CAGR of 9.06 % during the forecast period and is estimated to reach USD 6.89 billion by 2035.

The increasing number of surgical procedures worldwide is significantly boosting the growth of the global tissue adhesives market. According to the United Nations, 2023, as the global population grows and ages—1 in 6 people are now aged 65 or older, a figure projected to rise to 1 in 4 by 2050 demand for both elective and emergency surgeries continue to surge. According to the MRFR secondary analysis, over 360 million major surgical procedures were performed globally in 2023, driven by aging demographics and chronic disease prevalence. Moreover, 2024 Annals of Surgery meta-analysis highlighted that tissue adhesives are increasingly preferred by surgeons for wound closure due to their advantages over traditional sutures, including 30–50% faster application times and a 35% reduction in surgical site infections. Additionally, patients treated with tissue adhesives experience 20–25% shorter recovery periods, which is critical for improving post-operative outcomes.

The global tissue adhesives market is projected to grow at a significant rate, fueled by adoption in specialties such as dermatology, orthopedics, and cardiovascular surgery. For instance, American Society for Dermatologic Surgery, Dermatologists who are members of the American Society for Dermatologic Surgery (ASDS carried out almost 14 million medically essential and cosmetic procedures in 2019, marking an 11% increase from 2018 and a 78% rise since 2012 with tissue adhesives preferred for minimizing scarring in cosmetic surgeries. According to the European Commission, in 2022, a total of 1.06 million transluminal coronary angioplasty procedures were performed across the 25 EU countries with available data. This represents an increase of more than 3,500 procedures compared to 2017. As per the Journal of Minimally Invasive Surgery, 2024, with 85% of surgeries expected to adopt minimally invasive techniques by 2030, tissue adhesives are pivotal in reducing complications such as postoperative leakage by 40% and enhancing patient satisfaction. This trend underscores their essential role in advancing surgical precision, efficiency, and recovery outcomes worldwide.

Access Full Report @ https://www.marketresearchfuture.com/reports/tissue-adhesives-market-59652

Segmental Analysis

The Global Tissue Adhesives Market has been segmented based on Type, by Application, by End-User.

Based on Type, this segment includes Synthetic & Semi-Synthetic Adhesives (Cyanoacrylates, Polyethylene Glycol, Gelatin-Formaldehyde, Others), Natural Adhesives (Fibrin, Collagen, Dextran, Chitosan, Others). The Synthetic & Semi-Synthetic Adhesives segment dominated the global market in 2024, while the Natural Adhesives segment is projected to be the fastest–growing segment during the forecast period. This dominance is primarily due to their strong bonding properties, faster polymerization, and widespread use in various surgical procedures. Their versatility and proven performance in achieving hemostasis and wound closure have further reinforced their market position. However, the Natural Adhesives segment—which includes fibrin, collagen, dextran, and chitosan—is projected to be the fastest-growing during the forecast period. This growth is driven by the increasing demand for bio-compatible, biodegradable, and non-toxic solutions that reduce the risk of adverse reactions. Moreover, advancements in natural biomaterials and rising preference for minimally invasive procedures are fueling the adoption of natural adhesives, especially in delicate surgeries and regenerative medicine. This shift reflects growing emphasis on patient safety and improved healing outcomes.

Based on Application, this segment includes Surgery (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery), Plastic & Reconstructive Surgery (Ophthalmic Surgery, Urological Surgery, Thoracic Surgery, Others), Wound Care, Burn Treatment. The Surgery segment dominated the global market in 2024, while the Wound Care segment is projected to be the fastest–growing segment during the forecast period. This is largely due to the high volume of surgical procedures worldwide and the critical role adhesives play in ensuring effective wound closure, reducing operative time, and minimizing infection risks. This growth is driven by the rising incidence of chronic wounds, diabetic ulcers, and traumatic injuries, particularly among aging and diabetic populations. Additionally, increasing demand for non-invasive and easy-to-apply adhesive products in outpatient settings is accelerating the adoption of surgical adhesives in wound care, reflecting a shift toward advanced and patient-friendly healing solutions.

Based on End-User, this segment includes Hospitals and Specialty Clinics, Ambulatory Surgical Centers (ASCs), Research Laboratories & Institutes. The Hospitals and Specialty Clinics segment dominated the global market in 2024, while the Ambulatory Surgical Centers (ASCs) segment is projected to be the fastest–growing segment during the forecast period. Hospitals often handle complex and emergency cases, requiring reliable adhesive solutions for effective wound closure and hemostasis. This growth is fueled by the increasing preference for minimally invasive procedures, shorter recovery times, and cost-efficiency offered by ASCs. As healthcare systems globally emphasize outpatient care and patient convenience, the demand for quick and effective surgical adhesives in these centers is rising. Additionally, ASCs are rapidly adopting advanced technologies, further contributing to their market growth momentum.

Regional Analysis

Geographically, the Global Tissue Adhesives Market has been segmented into North America, Europe, Asia-Pacific and Rest of the World.

Major demand factors driving the North America market are the increasing surgical procedures and technological advancements in tissue adhesive products and aging population across the globe. The region also benefits from strong regulatory support, growing adoption of minimally invasive surgeries, and a significant aging population that contributes to increased demand for surgical interventions and wound care solutions. Additionally, the presence of key market players and higher healthcare spending further bolster market growth in North America. This growth is attributed to rising healthcare investments, expanding medical tourism, and a growing elderly population. Furthermore, increasing awareness of advanced wound care solutions and improvements in healthcare access across countries like China, India, and Japan are accelerating market expansion in the region.

Key Findings of the Study

• The Global Tissue Adhesives Market is expected to reach USD 6.89 billion by 2035, at a CAGR of 9.06% during the forecast period.


• The North America region accounted for the fastest-growing global market.


• Based on the Type, the Synthetic & Semi-Synthetic Adhesives segment was attributed to holding the largest market in 2024.


• Meyer-Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC, Becton, Dickinson and Company, B. Braun SE, Artivion, GEM SRL, Advanced Medical Solutions, Cohera Medical, Inc. are some of the players in the market.